Structures by: Iqbal M. S.
Total: 32
3-(2-Benzamidophenyl)-4-(4-hydroxyphenyl)-5-methyl-4<i>H</i>-1,2,4- triazol-1-ium chloride
C22H19N4O2,Cl
Acta Crystallographica Section E (2008) 64, 8 o1505
a=17.1336(15)Å b=9.8967(9)Å c=12.1910(10)Å
α=90.00° β=90.00° γ=90.00°
(1<i>R</i>,2<i>S</i>,4<i>S</i>,5<i>S</i>)-4-(4-fluorophenyl)- 2-hydroperoxy-4-hydroxy-2-isopropyl-<i>N</i>,5-diphenyl-3,6- dioxabicyclo[3.1.0]hexane-1-carboxamide
C26H24FNO6
Acta Crystallographica Section E (2008) 64, 8 o1548
a=11.7560(6)Å b=11.7489(6)Å c=17.0889(9)Å
α=90.00° β=94.438(2)° γ=90.00°
<i>N</i>'-[(1<i>E</i>)-1-(4-Chlorophenyl)ethylidene]formohydrazide
C9H9ClN2O
Acta Crystallographica Section E (2009) 65, 10 o2494
a=5.9373(5)Å b=6.2178(4)Å c=25.3495(18)Å
α=90° β=93.900(4)° γ=90°
<i>N</i>'-[(<i>E</i>)-(4-Bromo-2-thienyl)methylidene]benzohydrazide 0.06-hydrate
C12H9BrN2OS,0.06(H2O)
Acta Crystallographica Section E (2009) 65, 10 o2501
a=8.8348(4)Å b=18.3446(10)Å c=15.6788(6)Å
α=90° β=90.274(2)° γ=90°
3-Benzyl-5-butyl-1,3,5-thiadiazinane-2-thione
C14H20N2S2
Acta Crystallographica Section E (2009) 65, 3 o468
a=7.6559(2)Å b=9.9586(3)Å c=11.1531(4)Å
α=66.917(2)° β=70.6490(10)° γ=76.076(2)°
<i>N</i>'-[(<i>E</i>)-1-(3-Fluorophenyl)ethylidene]formohydrazide
C9H9FN2O
Acta Crystallographica Section E (2009) 65, 11 o2830
a=6.8466(5)Å b=7.0258(6)Å c=9.9419(8)Å
α=70.558(5)° β=81.267(5)° γ=73.977(4)°
3-Hydroxy-<i>N</i>'-[(<i>Z</i>)-(5-methyl-2-furyl)methylidene]naphthalene- 2-carbohydrazide
C17H14N2O3
Acta Crystallographica Section E (2009) 65, 11 o2845-o2846
a=10.604(4)Å b=12.321(5)Å c=18.615(3)Å
α=71.351(5)° β=73.742(4)° γ=84.280(5)°
2-Hydroxy-3-nitrobenzamide
C7H6N2O4
Acta Crystallographica Section E (2009) 65, 7 o1630
a=3.8390(2)Å b=13.0347(8)Å c=16.0409(9)Å
α=98.207(3)° β=95.658(2)° γ=98.365(3)°
(2-Aminophenyl)[(5<i>S</i>)-5-hydroxy-3,5-dimethyl-4,5-dihydro-1<i>H</i>-\ pyrazol-1-yl]methanone
C12H15N3O2
Acta Crystallographica Section E (2009) 65, 8 o1834-o1835
a=23.5705(7)Å b=11.3547(4)Å c=9.1848(3)Å
α=90° β=90° γ=90°
(2<i>R</i>)-2-(1,3-Dioxoisoindolin-2-yl)-4-(methylsulfanyl)butanoic acid
C13H13NO4S
Acta Crystallographica Section E (2009) 65, 8 o2002
a=6.7923(6)Å b=9.9581(8)Å c=20.0970(17)Å
α=90° β=90° γ=90°
4-(3-Nitrophenyl)-1-(2-oxoindolin-3-ylidene)thiosemicarbazide
C15H11N5O3S
Acta Crystallographica Section E (2010) 66, 6 o1405
a=18.5545(10)Å b=15.3852(8)Å c=5.3367(4)Å
α=90° β=90° γ=90°
Benzydaminium cephazolinate
C19H24N3O,C14H13N8O4S3
Acta Crystallographica Section E (2009) 65, 12 o3132-o3133
a=44.409(3)Å b=7.1777(5)Å c=11.2683(8)Å
α=90° β=90.587(8)° γ=90°
2-Hydroxy-5-nitrobenzamide
C7H6N2O4
Acta Crystallographica Section E (2009) 65, 12 o3260
a=5.1803(3)Å b=11.1037(8)Å c=13.7214(10)Å
α=90° β=100.642(4)° γ=90°
Methyl 2-methyl-3,5-dinitrobenzoate
C9H8N2O6
Acta Crystallographica Section E (2010) 66, 2 o288
a=6.7948(5)Å b=8.8478(8)Å c=17.3539(17)Å
α=90° β=90° γ=90°
4-(2-Fluorophenyl)-1-(2-oxoindolin-3-ylidene)thiosemicarbazide
C15H11FN4OS
Acta Crystallographica Section E (2010) 66, 5 o1018
a=5.7646(3)Å b=18.4939(12)Å c=13.6772(8)Å
α=90° β=91.212(3)° γ=90°
2-[6-Thioxo-5-(2,4,6-trimethylphenyl)-1,3,5-thiadiazinan-3-yl]acetic acid
C14H18N2O2S2
Acta Crystallographica Section E (2009) 65, 4 o902
a=6.9134(4)Å b=17.6934(11)Å c=24.9073(15)Å
α=90° β=90° γ=90°
C9H10N3O,C7H7O3S,H2O
C9H10N3O,C7H7O3S,H2O
Acta Crystallographica Section E (2009) 65, 5 o1051
a=20.8380(10)Å b=6.2769(3)Å c=14.7897(7)Å
α=90° β=116.6760(10)° γ=90°
<i>N</i>'-[(<i>E</i>)-(5-methylfuran-2-yl)methylidene]formohydrazide
C7H8N2O2
Acta Crystallographica Section E (2009) 65, 10 o2495
a=10.6433(14)Å b=6.7762(8)Å c=21.129(3)Å
α=90° β=90° γ=90°
<i>N</i>'-[(<i>E</i>)-(4-Bromo-2-thienyl)methylene]isonicotinohydrazide
C11H8BrN3OS
Acta Crystallographica Section E (2009) 65, 10 o2496
a=14.3507(6)Å b=48.732(2)Å c=7.2115(3)Å
α=90° β=90° γ=90°
2-(<i>tert</i>-Butoxycarbonylamino)-2-(2-fluorophenyl)acetic acid
C13H16FNO4
Acta Crystallographica Section E (2009) 65, 11 o2891
a=5.3065(3)Å b=10.6264(6)Å c=12.4930(6)Å
α=106.175(3)° β=95.175(2)° γ=100.728(3)°
<i>N</i>'-[(<i>E</i>)-4-Hydroxy-3-methoxybenzylidene]pyridine-4-carbohydrazide
C14H13N3O3
Acta Crystallographica Section E (2009) 65, 11 o2899
a=14.8543(10)Å b=12.4943(9)Å c=7.7162(5)Å
α=90° β=116.716(2)° γ=90°
1-(5-Nitro-2-oxoindolin-3-ylidene)-4-<i>o</i>-tolylthiosemicarbazide methanol monosolvate
C16H13N5O3S,CH4O
Acta Crystallographica Section E (2009) 65, 11 o2858
a=14.2485(5)Å b=7.6986(3)Å c=18.5937(6)Å
α=90° β=119.847(2)° γ=90°
<i>N</i>'-[(<i>E</i>)-4-Hydroxy-3-methoxybenzylidene]benzohydrazide
C15H14N2O3
Acta Crystallographica Section E (2009) 65, 11 o2898
a=18.6994(8)Å b=18.6994(8)Å c=15.7223(12)Å
α=90° β=90° γ=90°
(<i>Z</i>)-4-Hexyl-1-(5-nitro-2-oxo-2,3-dihydro-1<i>H</i>-indol-3- ylidene)thiosemicarbazide
C15H19N5O3S
Acta Crystallographica Section E (2009) 65, 11 o2698-o2699
a=11.9464(6)Å b=4.8845(3)Å c=29.9688(17)Å
α=90° β=101.131(3)° γ=90°
4-(5-Chloro-2-methylphenyl)-1-[2-oxo-5-(trifluoromethoxy)indolin-3- ylidene]thiosemicarbazide
C17H12ClF3N4O2S
Acta Crystallographica Section E (2010) 66, 5 o1169-o1170
a=10.5808(5)Å b=11.0262(5)Å c=17.1743(7)Å
α=102.855(3)° β=94.766(3)° γ=107.814(2)°
4-(3-Methoxyphenyl)-1-(2-oxoindolin-3-ylidene)thiosemicarbazide
C16H14N4O2S
Acta Crystallographica Section E (2010) 66, 6 o1404
a=15.1793(5)Å b=7.2473(2)Å c=15.4764(5)Å
α=90.00° β=111.179(2)° γ=90.00°
4-(2-Ethylphenyl)-1-(2-oxoindolin-3-ylidene)thiosemicarbazide
C17H16N4OS
Acta Crystallographica Section E (2010) 66, 7 o1609
a=25.6769(7)Å b=7.4340(2)Å c=16.6548(5)Å
α=90° β=96.2480(10)° γ=90°
1-[2-Oxo-5-(trifluoromethoxy)indolin-3-ylidene]-4-[4- (trifluoromethyl)phenyl]thiosemicarbazide
C17H10F6N4O2S
Acta Crystallographica Section E (2010) 66, 7 o1749
a=7.5452(11)Å b=8.3177(13)Å c=16.048(2)Å
α=104.452(6)° β=94.752(7)° γ=103.606(7)°
1-(2-Oxoindolin-3-ylidene)-4-[2-(trifluoromethoxy)phenyl]thiosemicarbazide
C16H11F3N4O2S
Acta Crystallographica Section E (2010) 66, 9 o2447
a=13.4746(8)Å b=13.4746(8)Å c=18.1073(10)Å
α=90° β=90° γ=90°
4-{[(<i>E</i>)-2,3-Dihydroxybenzylidene]amino}- <i>N</i>-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide
C17H15N3O5S
Acta Crystallographica Section E (2012) 68, 7 o2125
a=7.1881(6)Å b=10.6682(10)Å c=11.6865(9)Å
α=92.181(4)° β=99.776(4)° γ=99.606(5)°
2-[(<i>E</i>)-({4-[(4,6-Dimethylpyrimidin-2-yl)sulfamoyl]phenyl}iminio)methyl]- 6-hydroxyphenolate
C19H18N4O4S
Acta Crystallographica Section E (2012) 68, 9 o2687
a=24.7506(12)Å b=12.1689(6)Å c=12.8408(5)Å
α=90° β=90° γ=90°
(2<i>Z</i>)-<i>N</i>-(2-Chlorobenzyl)-2-(2-oxo-2,3-dihydro-1<i>H</i>-indol- 3-ylidene)hydrazinecarbothioamide
C16H13ClN4OS
Acta Crystallographica Section E (2012) 68, 9 o2731
a=13.7017(10)Å b=14.1585(10)Å c=8.2698(5)Å
α=90° β=93.151(3)° γ=90°